Oncology

Immunotherapy changing metastatic melanoma survivorship

  The overall survival of patients with metastatic melanoma has significantly increased with the use of immune checkpoint inhibitors (ICIs), leading to a growing group of metastatic melanoma survivors with unique survivorship care (SSC). A study involving 20 patients with metastatic melanoma whose treatment with ICIs was discontinued after ongoing...